HK1220176A1 - 用於 -二甲基- -二氫- -喹喔啉- -酮衍生物的生產方法及用於所述生產方法的中間體 - Google Patents

用於 -二甲基- -二氫- -喹喔啉- -酮衍生物的生產方法及用於所述生產方法的中間體

Info

Publication number
HK1220176A1
HK1220176A1 HK16108118.2A HK16108118A HK1220176A1 HK 1220176 A1 HK1220176 A1 HK 1220176A1 HK 16108118 A HK16108118 A HK 16108118A HK 1220176 A1 HK1220176 A1 HK 1220176A1
Authority
HK
Hong Kong
Prior art keywords
production method
quinoxaline
dihydro
dimethyl
derivative
Prior art date
Application number
HK16108118.2A
Other languages
English (en)
Inventor
Kazuhiro Kudou
Masato Nagatsuka
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of HK1220176A1 publication Critical patent/HK1220176A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16108118.2A 2013-08-09 2016-07-12 用於 -二甲基- -二氫- -喹喔啉- -酮衍生物的生產方法及用於所述生產方法的中間體 HK1220176A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013166643 2013-08-09
PCT/JP2014/071053 WO2015020204A1 (ja) 2013-08-09 2014-08-08 3,3-ジメチル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体の製造方法およびその製造方法の中間体

Publications (1)

Publication Number Publication Date
HK1220176A1 true HK1220176A1 (zh) 2017-04-28

Family

ID=52461528

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16108118.2A HK1220176A1 (zh) 2013-08-09 2016-07-12 用於 -二甲基- -二氫- -喹喔啉- -酮衍生物的生產方法及用於所述生產方法的中間體
HK16108543.7A HK1220462A1 (zh) 2013-08-09 2016-07-19 -二甲基- -二氫- -喹喔啉- -酮衍生物的製造方法及該製造方法的中間體

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16108543.7A HK1220462A1 (zh) 2013-08-09 2016-07-19 -二甲基- -二氫- -喹喔啉- -酮衍生物的製造方法及該製造方法的中間體

Country Status (10)

Country Link
US (2) US9676703B2 (zh)
EP (1) EP3031802A4 (zh)
JP (1) JP2015057381A (zh)
KR (1) KR20160040298A (zh)
CN (1) CN105473557A (zh)
CA (1) CA2920353A1 (zh)
HK (2) HK1220176A1 (zh)
RU (1) RU2016107848A (zh)
TW (1) TW201536760A (zh)
WO (1) WO2015020204A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200121652A1 (en) 2017-06-16 2020-04-23 The Doshisha Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent
AU2018283250B2 (en) 2017-06-16 2022-09-01 The Doshisha mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209965D1 (de) 1991-04-15 2002-10-17 Aventis Pharma Gmbh Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
WO2004050659A1 (en) * 2002-11-27 2004-06-17 Eli Lilly And Company Novel compounds as pharmaceutical agents
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7256294B2 (en) 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
MY147756A (en) 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
WO2007041077A2 (en) * 2005-09-30 2007-04-12 Janssen Pharmaceutica N.V. Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
CA2643070C (en) 2006-03-14 2016-01-26 Santen Pharmaceutical Co., Ltd. Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
BRPI1010649A2 (pt) 2009-06-08 2016-06-07 Gruenenthal Gmbh benzimidazóis, benzotiazóis e benzoxazoles substituídos.

Also Published As

Publication number Publication date
US9676703B2 (en) 2017-06-13
RU2016107848A (ru) 2017-09-15
EP3031802A4 (en) 2017-07-12
CN105473557A (zh) 2016-04-06
US20160200690A1 (en) 2016-07-14
HK1220462A1 (zh) 2017-05-05
RU2016107848A3 (zh) 2018-05-31
EP3031802A1 (en) 2016-06-15
WO2015020204A1 (ja) 2015-02-12
CA2920353A1 (en) 2015-02-12
KR20160040298A (ko) 2016-04-12
JP2015057381A (ja) 2015-03-26
TW201536760A (zh) 2015-10-01
US20170247342A1 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
EP3006415A4 (en) PROCESS FOR PRODUCING NANOCEMENT AND NANOCEMENT
HUE046096T2 (hu) Retenciós eszköz, valamint eljárás az elõállítására
PL2981640T3 (pl) Włókno polisacharydowe i sposób jego wytwarzania
ZA201604328B (en) 1,2-naphthoquinone derivative and method for preparing same
EP2974766A4 (en) BALLOON AND PROCESS FOR PRODUCING THE SAME
HK1218496A1 (zh) 乾燥速食面及其製造方法
EP2949639A4 (en) PREPARATION FOR ALPHA, ALPHA-DIFLUORACETALDEHYDE
EP3009400A4 (en) LEV TYPE ZEOLITE AND METHOD FOR PRODUCING THE SAME
EP2960338A4 (en) SUGAR SOLUTION PROCESS
HK1218893A1 (zh) 蛋白質的生產方法
EP2978011A4 (en) PROCESS FOR PREPARING A COMPLEX AND COMPOSITION
GB201305947D0 (en) New method 1
PL3091005T3 (pl) Pochodna 1,2-naftochinonu i sposób jej wytwarzania
HUE037007T2 (hu) Eljárás pirrol származék elõállítására és annak intermediere
SG11201507951SA (en) Method for producing 2,7-octadien-1-ol
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP2952108A4 (en) METHOD FOR PRODUCING CIGARETTES, CIGARETTE AND DOUBLE CIGARETTE
EP2868476A4 (en) PROCESS FOR PRODUCING PRINTED MEDIA
HK1220462A1 (zh) -二甲基- -二氫- -喹喔啉- -酮衍生物的製造方法及該製造方法的中間體
HUE037141T2 (hu) Eljárás 1,1-dibróm-1-fluoretán elõállítására
PL2980053T3 (pl) Sposób wytwarzania butadienu
IL250223A0 (en) A method for the preparation of the pyrimidin-1-ol compound, and its intermediates
EP3045442A4 (en) Method for producing cyclolavandulol and derivative thereof
EP3053908A4 (en) PROCESS FOR PREPARING ALPHA-HALOGENOACETOPHENONE COMPOUND AND ALPHA-BROMOACETOPHENONE COMPOUND
HK1244814A1 (zh) 一種薯蕷皂苷元-3-位衍生物及其製備方法和用途